EC
MRNA icon

EMS Capital’s Moderna MRNA Stock Holding History

EMS Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,350
Closed -$317K – 23
2021
Q2 		$317K Buy
+1,350
New +$241K 0.02% 24
2021
Q1 		– Sell
-66,607
Closed -$6.96M – 32
2020
Q4 		$6.96M Buy
+66,607
New +$6.74M 0.53% 23
2020
Q3 		– Sell
-84,800
Closed -$5.45M – 28
2020
Q2 		$5.45M Buy
+84,800
New +$4.64M 0.44% 22

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

EMS Capital's MRNA Position: Q3 2021 in Review

EMS Capital sold out of Moderna (MRNA) in Q3 2021, closing a stake of 1,350 shares — an estimated $317K sold.

EMS Capital first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $6.96M in Q4 2020. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • EMS Capital reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • EMS Capital sold 1,350 Moderna shares in Q3 2021, an estimated $317K.
  • EMS Capital first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
  • EMS Capital's Moderna position peaked at $6.96M in Q4 2020.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on EMS Capital's 13F filing for Q3 2021, filed 15 Nov 2021.